Construction and expression of a soluble form of human CD30 ligand with functional activity

Isabelle F. Powell, Tianhong Li, Hans Martin Jäck, Thomas M. Ellis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

CD30 engagement in human lymphoid cells induces pleiotropic cellular responses that affect cellular viability and proliferation, cytokine production, and nuclear factor κB (NF-κB) nuclear translocation. Studies examining the molecular basis for this pleiotropism thus far have relied on the use of antibodies and cells transfected with CD30L to trigger CD30, two methods of receptor induction that present important limitations: antibodies are not physiological receptor-triggering molecules and CD30L transfectants induce high background intracellular signaling in the cells under study. We have generated and expressed a functional soluble human CD30L molecule (sCD30L/CD8α) comprised of the extracellular domain of human CD30L fused to the extracellular domain of the human CD8α chain. Immunoprecipitation and Western blot analysis of sCD30L/CD8α revealed the existence of at least two forms of sCD30L/CD8α, which exhibited molecular sizes consistent with the existence of monomeric and trimeric forms of the molecule. Binding analyses performed using a soluble CD30 fusion protein (sCD30/γ1) confirmed the ability of sCD30L/CD8α to bind to CD30. Functionally, immobilized sCD30L/CD8α-induced cell death in the CD30-expressing lines Karpas-299 and HDLM-2 and reduced proliferative levels in Karpas-299; these effects were inhibitable by the addition of sCD30/γ1. These studies demonstrate the utility of sCD30L/CD8α in characterizing the normal function of CD30L and CD30 and indicate the natural ability of soluble forms of CD30L to trimerize.

Original languageEnglish (US)
Pages (from-to)752-757
Number of pages6
JournalJournal of Leukocyte Biology
Volume63
Issue number6
StatePublished - Jun 1998
Externally publishedYes

Fingerprint

Antibodies
Immunoprecipitation
Cell Death
Western Blotting
Cell Proliferation
Lymphocytes
Cytokines
human TNFSF8 protein
Proteins

Keywords

  • T lymphocytes
  • Tumor necrosis factor receptor

ASJC Scopus subject areas

  • Cell Biology

Cite this

Construction and expression of a soluble form of human CD30 ligand with functional activity. / Powell, Isabelle F.; Li, Tianhong; Jäck, Hans Martin; Ellis, Thomas M.

In: Journal of Leukocyte Biology, Vol. 63, No. 6, 06.1998, p. 752-757.

Research output: Contribution to journalArticle

Powell, Isabelle F. ; Li, Tianhong ; Jäck, Hans Martin ; Ellis, Thomas M. / Construction and expression of a soluble form of human CD30 ligand with functional activity. In: Journal of Leukocyte Biology. 1998 ; Vol. 63, No. 6. pp. 752-757.
@article{f0745d8d18f1452f9d266511867f3e15,
title = "Construction and expression of a soluble form of human CD30 ligand with functional activity",
abstract = "CD30 engagement in human lymphoid cells induces pleiotropic cellular responses that affect cellular viability and proliferation, cytokine production, and nuclear factor κB (NF-κB) nuclear translocation. Studies examining the molecular basis for this pleiotropism thus far have relied on the use of antibodies and cells transfected with CD30L to trigger CD30, two methods of receptor induction that present important limitations: antibodies are not physiological receptor-triggering molecules and CD30L transfectants induce high background intracellular signaling in the cells under study. We have generated and expressed a functional soluble human CD30L molecule (sCD30L/CD8α) comprised of the extracellular domain of human CD30L fused to the extracellular domain of the human CD8α chain. Immunoprecipitation and Western blot analysis of sCD30L/CD8α revealed the existence of at least two forms of sCD30L/CD8α, which exhibited molecular sizes consistent with the existence of monomeric and trimeric forms of the molecule. Binding analyses performed using a soluble CD30 fusion protein (sCD30/γ1) confirmed the ability of sCD30L/CD8α to bind to CD30. Functionally, immobilized sCD30L/CD8α-induced cell death in the CD30-expressing lines Karpas-299 and HDLM-2 and reduced proliferative levels in Karpas-299; these effects were inhibitable by the addition of sCD30/γ1. These studies demonstrate the utility of sCD30L/CD8α in characterizing the normal function of CD30L and CD30 and indicate the natural ability of soluble forms of CD30L to trimerize.",
keywords = "T lymphocytes, Tumor necrosis factor receptor",
author = "Powell, {Isabelle F.} and Tianhong Li and J{\"a}ck, {Hans Martin} and Ellis, {Thomas M.}",
year = "1998",
month = "6",
language = "English (US)",
volume = "63",
pages = "752--757",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - Construction and expression of a soluble form of human CD30 ligand with functional activity

AU - Powell, Isabelle F.

AU - Li, Tianhong

AU - Jäck, Hans Martin

AU - Ellis, Thomas M.

PY - 1998/6

Y1 - 1998/6

N2 - CD30 engagement in human lymphoid cells induces pleiotropic cellular responses that affect cellular viability and proliferation, cytokine production, and nuclear factor κB (NF-κB) nuclear translocation. Studies examining the molecular basis for this pleiotropism thus far have relied on the use of antibodies and cells transfected with CD30L to trigger CD30, two methods of receptor induction that present important limitations: antibodies are not physiological receptor-triggering molecules and CD30L transfectants induce high background intracellular signaling in the cells under study. We have generated and expressed a functional soluble human CD30L molecule (sCD30L/CD8α) comprised of the extracellular domain of human CD30L fused to the extracellular domain of the human CD8α chain. Immunoprecipitation and Western blot analysis of sCD30L/CD8α revealed the existence of at least two forms of sCD30L/CD8α, which exhibited molecular sizes consistent with the existence of monomeric and trimeric forms of the molecule. Binding analyses performed using a soluble CD30 fusion protein (sCD30/γ1) confirmed the ability of sCD30L/CD8α to bind to CD30. Functionally, immobilized sCD30L/CD8α-induced cell death in the CD30-expressing lines Karpas-299 and HDLM-2 and reduced proliferative levels in Karpas-299; these effects were inhibitable by the addition of sCD30/γ1. These studies demonstrate the utility of sCD30L/CD8α in characterizing the normal function of CD30L and CD30 and indicate the natural ability of soluble forms of CD30L to trimerize.

AB - CD30 engagement in human lymphoid cells induces pleiotropic cellular responses that affect cellular viability and proliferation, cytokine production, and nuclear factor κB (NF-κB) nuclear translocation. Studies examining the molecular basis for this pleiotropism thus far have relied on the use of antibodies and cells transfected with CD30L to trigger CD30, two methods of receptor induction that present important limitations: antibodies are not physiological receptor-triggering molecules and CD30L transfectants induce high background intracellular signaling in the cells under study. We have generated and expressed a functional soluble human CD30L molecule (sCD30L/CD8α) comprised of the extracellular domain of human CD30L fused to the extracellular domain of the human CD8α chain. Immunoprecipitation and Western blot analysis of sCD30L/CD8α revealed the existence of at least two forms of sCD30L/CD8α, which exhibited molecular sizes consistent with the existence of monomeric and trimeric forms of the molecule. Binding analyses performed using a soluble CD30 fusion protein (sCD30/γ1) confirmed the ability of sCD30L/CD8α to bind to CD30. Functionally, immobilized sCD30L/CD8α-induced cell death in the CD30-expressing lines Karpas-299 and HDLM-2 and reduced proliferative levels in Karpas-299; these effects were inhibitable by the addition of sCD30/γ1. These studies demonstrate the utility of sCD30L/CD8α in characterizing the normal function of CD30L and CD30 and indicate the natural ability of soluble forms of CD30L to trimerize.

KW - T lymphocytes

KW - Tumor necrosis factor receptor

UR - http://www.scopus.com/inward/record.url?scp=0031749263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031749263&partnerID=8YFLogxK

M3 - Article

C2 - 9620669

AN - SCOPUS:0031749263

VL - 63

SP - 752

EP - 757

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 6

ER -